SCHEDULE OF COMPONENTS OF LIABILITIES AND REVENUE CLASSIFIED AS DISCONTINUED OPERATIONS (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Current assets of discontinued operations		$ 28		$ 28		$ 3,093
Current liabilities of discontinued operations		858		858		3,157
Income tax (benefit) expense		(11)	$ (714)	24	$ (684)
Discontinued Operations, Disposed of by Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Accounts receivable, net						1,486
Other		28		28		1,607
Current assets of discontinued operations		28		28		3,093
Property and equipment, net						6,032
Other intangible assets, net						5,155
Goodwill						8,433
Other						2,767
Long-term assets of discontinued operations						22,387
Total assets		28		28		25,480
Accounts payable						1,320
Accrued salary and bonus		92		92		335
Other	[1]	766		766		1,502
Current liabilities of discontinued operations		858		858		3,157
Operating lease liabilities, net of current portion						2,634
Other						71
Long-term liabilities of discontinued operations						2,705
Total liabilities		858		858		$ 5,862
Revenue, net		1,267	1,415	5,678	6,455
Loss from discontinued operations		(13,012)	(2,180)	(15,888)	(5,744)
Gain (loss) on sale of Pharma Solutions
Income tax (benefit) expense		(58)	62	48	175
Loss from discontinued operations, net of tax		$ (12,954)	$ (2,242)	$ (15,936)	$ (5,919)

[1] Includes $766 of liabilities related to the former Commercial Services business unit.